HTHSCI 2C06 Study Guide - Final Guide: Pulmonary Embolism, Mortality Rate, Smoking Cessation
20 Apr 2016
School
Department
Course
Professor
Document Summary
Respiratory disorder largely caused by smoking, which is characterized by progressive, partially reversible airway obstruction and lung hyperinflation, systemic manifestations, and increasing frequency and severity of exacerbations. 780,000 ontarians are living with copd (1 in 10) Est. to cost the on health care system . 3 billion in 2001. Causes more hospitalization than any other major chronic illness. Copd is the 4th leading cause of death in canada. Expected to become 3rd leading cause of death worldwide by 2020. In 2011: 36,000 people died with copd as a contributing factor. Women are increasing in numbers: smoking, work environment. Inflammation: persistent inflammation of small and large airways, lung parenchyma and its vasculature, airway inflammation is present even in early disease, inflammatory process persists long after smoking cessation. Laboratory test: spirometry (pre/post bronchodilator, essential for confirming the presence and possible reversibility of airflow obstruction and quantifying airflow obstruction.
